These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23837531)

  • 1. Factors influencing specialist care referral of multidrug- and extensively drug-resistant tuberculosis patients in Gauteng/South Africa: a descriptive questionnaire-based study.
    Nkosi D; Janssen S; Padanilam X; Louw R; Menezes CN; Grobusch MP
    BMC Health Serv Res; 2013 Jul; 13():268. PubMed ID: 23837531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.
    Ebonwu JI; Tint KS; Ihekweazu C
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1043-8. PubMed ID: 23827028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of comorbidity and need for up-referral among inpatients at a district-level hospital with specialist tuberculosis services in South Africa: the need for specialist support.
    Van der Plas H; Mendelson M
    S Afr Med J; 2011 Jul; 101(8):529-32. PubMed ID: 21920125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers.
    O'Donnell MR; Jarand J; Loveday M; Padayatchi N; Zelnick J; Werner L; Naidoo K; Master I; Osburn G; Kvasnovsky C; Shean K; Pai M; Van der Walt M; Horsburgh CR; Dheda K
    Ann Intern Med; 2010 Oct; 153(8):516-22. PubMed ID: 20956708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national infection control evaluation of drug-resistant tuberculosis hospitals in South Africa.
    Farley JE; Tudor C; Mphahlele M; Franz K; Perrin NA; Dorman S; Van der Walt M
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):82-9. PubMed ID: 22236851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exogenous reinfection as a cause of multidrug-resistant and extensively drug-resistant tuberculosis in rural South Africa.
    Andrews JR; Gandhi NR; Moodley P; Shah NS; Bohlken L; Moll AP; Pillay M; Friedland G; Sturm AW;
    J Infect Dis; 2008 Dec; 198(11):1582-9. PubMed ID: 18847372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health care workers' fears associated with working in multidrug- and or extensively-resistant tuberculosis wards in South Africa.
    Tudor C; Mphahlele M; Van der Walt M; Farley JE
    Int J Tuberc Lung Dis; 2013 Oct; 17(10 Suppl 1):22-29. PubMed ID: 24020597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of potentially infectious tuberculosis and multidrug-resistant tuberculosis (MDR-TB) among hospital inpatients in KwaZulu Natal, South Africa indicate risk of nosocomial transmission.
    Bantubani N; Kabera G; Connolly C; Rustomjee R; Reddy T; Cohen T; Pym AS
    PLoS One; 2014; 9(3):e90868. PubMed ID: 24625669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experience.
    Liu CH; Li L; Chen Z; Wang Q; Hu YL; Zhu B; Woo PC
    PLoS One; 2011 Apr; 6(4):e19399. PubMed ID: 21559362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
    Moodley P; Shah NS; Tayob N; Connolly C; Zetola N; Gandhi N; Friedland G; Sturm AW
    PLoS One; 2011; 6(5):e17513. PubMed ID: 21655324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
    Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
    BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study.
    Sharma SK; George N; Kadhiravan T; Saha PK; Mishra HK; Hanif M
    Indian J Med Res; 2009 Oct; 130(4):392-5. PubMed ID: 19942741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.
    Kim DH; Kim HJ; Park SK; Kong SJ; Kim YS; Kim TH; Kim EK; Lee KM; Lee SS; Park JS; Koh WJ; Lee CH; Shim TS
    Am J Respir Crit Care Med; 2010 Jul; 182(1):113-9. PubMed ID: 20224066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
    Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
    PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.
    Andrews JR; Shah NS; Weissman D; Moll AP; Friedland G; Gandhi NR
    PLoS One; 2010 Dec; 5(12):e15735. PubMed ID: 21209951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa.
    Pitso L; Potgieter S; Van der Spoel van Dijk A
    S Afr Med J; 2019 Aug; 109(9):659-664. PubMed ID: 31635590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant tuberculosis in Norway: a nationwide study, 1995-2014.
    Jensenius M; Winje BA; Blomberg B; Mengshoel AT; Lippe Bv; Hannula R; Bruun JN; Knudsen PK; Rønning JO; Heldal E; Dyrhol-Riise AM
    Int J Tuberc Lung Dis; 2016 Jun; 20(6):786-92. PubMed ID: 27155182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.